126 related articles for article (PubMed ID: 33155192)
21. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.
Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
[TBL] [Abstract][Full Text] [Related]
22. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.
Yao N; Sun JQ; Yu L; Ma L; Guo BQ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289
[TBL] [Abstract][Full Text] [Related]
23. TPM4 aggravates the malignant progression of hepatocellular carcinoma through negatively regulating SUSD2.
Sheng ZG; Chen MH
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4756-4765. PubMed ID: 32432739
[TBL] [Abstract][Full Text] [Related]
24. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
25. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
[TBL] [Abstract][Full Text] [Related]
26. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
Pei CL; Fei KL; Yuan XY; Gong XJ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
[TBL] [Abstract][Full Text] [Related]
27. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
[TBL] [Abstract][Full Text] [Related]
28. DERL3 suppresses colorectal cancer metastasis through negatively regulating MYCN level.
Yu F; Mou B; Sheng J; Liu J; Qin X; Yu J
Minerva Med; 2023 Jun; 114(3):316-322. PubMed ID: 32538588
[TBL] [Abstract][Full Text] [Related]
29. PIK3R6 Promotes Angiogenesis in Hepatocellular carcinoma by Activating STAT3 Signaling Pathway.
Du Y; Zhao W; Han H; Ren L; Ding M; Wang Y
Altern Ther Health Med; 2023 Nov; 29(8):704-709. PubMed ID: 37708538
[TBL] [Abstract][Full Text] [Related]
30. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
31. CircRNF20 aggravates the progression of non-small-cell lung carcinoma by activating MAPK9.
Wang ZX; Zhao Y; Wang YB; Zhang Q; Zou QX; Liang FH; Lin FW
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9981-9989. PubMed ID: 33090403
[TBL] [Abstract][Full Text] [Related]
32. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
33. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
Xiao C; Wang Y; Zheng M; Chen J; Song G; Zhou Z; Zhou C; Sun X; Zhong L; Ding E; Zhang Y; Yang L; Wu G; Xu S; Zhang H; Wang X
Cancer Sci; 2018 Apr; 109(4):1075-1087. PubMed ID: 29369481
[TBL] [Abstract][Full Text] [Related]
34. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MORT negatively regulates FGF1 to suppress malignant progression of breast cancer.
Yang Q; Yang D; Zhu HB; Li P; Wu XP; Tan YR
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6179-6186. PubMed ID: 34730198
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-1-3p inhibits the growth and metastasis of ovarian cancer cells by targeting DYNLT3.
Zhu FJ; Li JZ; Wang LL
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8713-8721. PubMed ID: 32964959
[TBL] [Abstract][Full Text] [Related]
37. Circ_0000515 drives the progression of hepatocellular carcinoma by regulating MAPK10.
Li H; Li CM; Yuan R; Wang HB; Wei J
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6014-6022. PubMed ID: 32572915
[TBL] [Abstract][Full Text] [Related]
38. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.
Jiang J; Xie C; Liu Y; Shi Q; Chen Y
Biomed Pharmacother; 2019 Jan; 109():595-601. PubMed ID: 30399596
[TBL] [Abstract][Full Text] [Related]
40. Circ_001680 stimulates glioma progression with the involvement of miR-186-5p.
Li J; Liu D; Cui Z
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6211-6218. PubMed ID: 32572887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
